Abstract
AbstractDetection of rare circulating tumor cells (CTCs) from patients has an important effect on clinical cancer diagnosis and prognosis. Here, an integrated microfluidic chip for efficient isolation and downstream analysis of CTCs is developed. This new designed platform, gelatin nanoparticle (GNP) integrated microchip, combines a series of curved herringbone structures, which generate enhanced interactions between CTCs and the immunomodified channel surface, with multifunctional GNP based nanostructured surface, which not only provide more binding sites for antibodies and targets and avoid nonspecific absorption of blood cells due to its electronegative surface charge, but also enable viable cell release under a mild enzymatic treatment. The chip allows cell isolation with ≈85% capture yield and ≈90% release efficiency using spiked cell samples. Results demonstrate that the released cancer cells maintain good viability and proliferation ability. Furthermore, the microchip is successfully applied to capture noninvasive release and genetically analyze CTCs from clinical cancer patients. The proposed platform may provide a potential in clinics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.